Woodline Partners »

Blueprint Medicines shares owned by Woodline Partners

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Woodline Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $30M 602k 50.22
2023-06-30 $18M 291k 63.20
2023-03-31 $4.7M 105k 44.99
2022-12-31 $11M 241k 43.81
2022-09-30 $6.2M 93k 65.89
2022-06-30 $5.9M 116k 50.51
2022-03-31 $1.6M 25k 63.88
2021-12-31 $6.6M 62k 107.11
2021-09-30 $18M 172k 102.81
2021-06-30 $5.0M 57k 87.97
2021-03-31 $8.6M 89k 97.23